Paradigm Biopharmaceuticals | PAR - Ebit

Stock Price
0.27
Daily Change
-0.01 -1.82%
Monthly
-16.92%
Yearly
-53.04%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported AUD-19.93M in EBIT for its fiscal semester ending in June of 2023.





Ebit Change Date
Avita Medical AUD -8.66M 1.61M Jun/2025
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge NZD -19.4M 2.91M Dec/2025
PYC Therapeutics AUD -25.84M 3M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025